Atlas Trials

Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8

RecordFirmDate
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events (NCT05038254)M.D. Anderson Cancer Center2021-05-12
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers (NCT04460937)National Cancer Institute (NCI)2021-04-09
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body (NCT04248452)ECOG-ACRIN Cancer Research Group2020-05-26
Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study (NCT04449679)Thomas Jefferson University2020-04-15
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)City of Hope Medical Center2019-12-24
Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma (NCT03395847)M.D. Anderson Cancer Center2018-02-09

Track Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.